RESUMEN
Paç Kisaarslan A, Sözeri B, Bastug F, Gündüz Z, Yel S, Nalçacioglu H, Sahin N, Özdemir Çiçek S, Poyrazoglu H, Düsünsel R. Elemental mercury intoxication in 7 patients admitted to a pediatric rheumatology clinic. Turk J Pediatr 2019; 61: 786-790. Mercury (Hg) is a toxic heavy metal that can be classified into three groups; organic (methyl), inorganic (mercuric), and elemental (metallic) mercury(Hg0). Mercury intoxication occurs mostly with the elemental form which can potentially damage the function of any organ, or any subcellular structure. The target organ of mercury is the brain, but peripheral nerve function, renal function, immune function, endocrine and muscle function, and several types of dermatitis have been described. We present 7 patients admitted to a pediatric rheumatology clinic with severe extremity pain. One of the patients had acrodynia, two of them had hypertension, two of them had tubulopathy, and three of them had neuropathy. The treatments were Dimercaptosuccinic acid and metalcaptase. In this report, we emphasize that mercury intoxication should be kept in mind with unexplained extremity pain. Timely diagnosis and treatment may prevent severe morbidity and mortality.
Asunto(s)
Intoxicación por Mercurio/diagnóstico , Acrodinia/etiología , Adolescente , Niño , Preescolar , Femenino , Humanos , Hipertensión/etiología , Masculino , Intoxicación por Mercurio/complicaciones , Intoxicación por Mercurio/terapia , ReumatologíaRESUMEN
Mercury intoxication is an uncommon cause of hypertension in children and can mimic several other diseases, such as pheochromocytoma and vasculitis. Mercury intoxication can present as a diagnostic challenge because levels of catecholamines may be elevated, suggesting that the etiology is a catecholamine-secreting tumor. Once acrodynia is identified as a primary symptom, a 24-hour urine mercury level can confirm the diagnosis. Inclusion of mercury intoxication in the differential diagnosis early on can help avoid unnecessary and invasive diagnostic tests and therapeutic interventions. We discuss a case of mercury intoxication in a 3-year-old girl presenting with hypertension and acrodynia, without a known history of exposure. Chelation therapy successfully treated our patient's mercury intoxication. However, it was also necessary to concurrently treat her hypertension and the pain associated with her acrodynia. Because there were no known risk factors for mercury poisoning in this case, and because ritual use of mercury is common in much of the United States, we recommend high clinical suspicion and subsequent testing in all cases of acrodynia.
Asunto(s)
Acrodinia/diagnóstico , Hipertensión/etiología , Compuestos de Mercurio/efectos adversos , Dolor Abdominal/etiología , Acrodinia/etiología , Acrodinia/terapia , Contaminación del Aire Interior/efectos adversos , Catecolaminas/análisis , Quelantes/uso terapéutico , Terapia por Quelación , Preescolar , Exposición a Riesgos Ambientales/efectos adversos , Exantema/etiología , Femenino , Humanos , Hipertensión/terapia , Compuestos de Mercurio/orina , Succímero/uso terapéutico , Taquicardia/etiologíaRESUMEN
Acrodynia, also known as pink disease, erythredema polyneuropathy, Feer syndrome, and raw-beef hands and feet, is thought to be a toxic reaction to elemental mercury and less commonly to organic and inorganic forms. Occurring commonly in the early 20th century, acrodynia is now a seemingly extinct disease in the modern world because of regulations to eliminate mercury from personal care products, household items, medications, and vaccinations. We present a case of a 3-year-old girl with acrodynia secondary to toxic exposure to elemental mercury in the home environment.
Asunto(s)
Acrodinia/etiología , Hipertensión/inducido químicamente , Intoxicación por Mercurio/diagnóstico , Mercurio/toxicidad , Acrodinia/diagnóstico , Acrodinia/tratamiento farmacológico , Antihipertensivos/uso terapéutico , Quelantes/uso terapéutico , Terapia por Quelación , Preescolar , Femenino , Pisos y Cubiertas de Piso , Humanos , Hipertensión/diagnóstico , Hipertensión/tratamiento farmacológico , Mercurio/orina , Intoxicación por Mercurio/tratamiento farmacológico , Succímero/uso terapéutico , Resultado del TratamientoRESUMEN
Mercury poisoning was once common in the 19th century. With its declining use, now clinicians and the public in general are often unaware and unsuspecting of mercury toxicity. A 40-year-old woman and her two children were hospitalized with a 1-week history of a generalized lichenoid eruption. Clinical improvement occurred without a diagnosis; however, on returning home, features of acrodynia with digital gangrene developed in the woman, leading to suspicion of heavy metal poisoning. There was no recurrence after moving from their contaminated house.
Asunto(s)
Erupciones Liquenoides/etiología , Intoxicación por Mercurio/complicaciones , Intoxicación por Mercurio/diagnóstico , Acrodinia/etiología , Adulto , Niño , Femenino , Dedos/patología , Gangrena/etiología , Humanos , Masculino , Intoxicación por Mercurio/patologíaRESUMEN
An infant presented with failure to thrive and developmental regression. Physical examination revealed an irritable child with swollen, erythematous extremities, and elevated blood pressure. Extensive investigations, including a metabolic work-up and neuroimaging, were unrevealing. Exposure to self-purchased medication was initially denied. The physical signs were suggestive of acrodynia. Mercury poisoning was ultimately established by measuring paired blood and urine mercury levels. On further enquiry, it was revealed that the child had been given a Chinese medicinal product for 4 months. He responded well to a chelating agent. Acrodynia is a childhood disease considered to be of historical interest only, but making a diagnosis of mercury poisoning is rewarding because the response to treatment is good. This case highlights the common misconception that alternative medicines are safe and benign.
Asunto(s)
Acrodinia , Terapias Complementarias/efectos adversos , Discapacidades del Desarrollo/inducido químicamente , Insuficiencia de Crecimiento/inducido químicamente , Intoxicación por Mercurio , Acrodinia/sangre , Acrodinia/etiología , Acrodinia/orina , Hong Kong , Humanos , Lactante , Masculino , Intoxicación por Mercurio/sangre , Intoxicación por Mercurio/diagnóstico , Intoxicación por Mercurio/fisiopatología , Intoxicación por Mercurio/orinaRESUMEN
A superantigen or autoimmunity has been hypothesized to be the main cause of the Kawasaki's Disease but the etiology is unknown. Medical literature, epidemiological findings, and some case reports have suggested that mercury may play a pathogenic role. Several patients with Kawasaki's Disease have presented with elevated urine mercury levels compared to matched controls. Most symptoms and diagnostic criteria which are seen in children with acrodynia, known to be caused by mercury, are similar to those seen in Kawasaki's Disease. Genetic depletion of glutathione S-transferase , a susceptibility marker for Kawasaki's Disease, is known to be also a risk factor for acrodynia and may also increase susceptibility to mercury . Coinciding with the largest increase (1985-1990) of thimerosal (49.6% ethyl mercury) in vaccines, routinely given to infants in the U.S. by 6 months of age (from 75microg to 187.5microg), the rates of Kawasaki's Disease increased ten times, and, later (1985-1997), by 20 times. Since 1990 88 cases of patients developing Kawasaki's Disease some days after vaccination have been reported to the Centers of Disease Control (CDC) including 19% manifesting symptoms the same day. The presented pathogenetic model may lead to new preventive- and therapeutic strategies for Kawasaki's disease.
Asunto(s)
Acrodinia/etiología , Mercurio/toxicidad , Síndrome Mucocutáneo Linfonodular/etiología , Acrodinia/epidemiología , Acrodinia/orina , Preescolar , Amalgama Dental/efectos adversos , Compuestos de Etilmercurio/toxicidad , Femenino , Predisposición Genética a la Enfermedad , Humanos , Lactante , Masculino , Compuestos de Metilmercurio/toxicidad , Síndrome Mucocutáneo Linfonodular/epidemiología , Síndrome Mucocutáneo Linfonodular/orina , Timerosal/toxicidad , Resultado del Tratamiento , Vacunación/efectos adversosRESUMEN
A 2-year-old girl presented with hypertension, anorexia and vomiting, restlessness, insomnia and acrodynia. Her blood pressure upon arrival was 145/98 mmHg. Ultrasound of the abdomen, CT scan of chest, abdomen and pelvis, and echocardiogram, were normal. Urinary levels of catecholamines were elevated, urine level of mercury was found to be high (33.2 microg/g creatinine), although blood level was normal (>0.5 microg/dl, reference value 0-4 microg/dl). Following a 1-month course of oral treatment with dimercaptosuccinic acid (DMSA) the child's symptoms and signs resolved, and urinary mercury and catecholamines levels normalized. Mercury intoxication should be suspected in a patient with severe hypertension, personality changes and acrodynia. Normal blood levels of mercury do not exclude this diagnosis, and catecholamine levels may serve as a surrogate marker for confirmation of the diagnosis and to evaluate response to treatment.
Asunto(s)
Acrodinia/diagnóstico , Hipertensión/diagnóstico , Intoxicación por Mercurio/diagnóstico , Acrodinia/etiología , Antídotos/uso terapéutico , Biomarcadores/orina , Catecolaminas/orina , Quelantes/uso terapéutico , Preescolar , Femenino , Humanos , Hipertensión/inducido químicamente , Mercurio/orina , Intoxicación por Mercurio/complicaciones , Intoxicación por Mercurio/orina , Succímero/uso terapéutico , Resultado del TratamientoRESUMEN
Mercury vapor poisoning is a serious and potentially fatal problem. Neurological manifestations involving the central nervous system are seen with chronic mercury intoxication. We present the case of a 10-year-old child who demonstrated acrodynia, seizures, and visual impairment following 20 days of exposure to elemental mercury at home. The initial blood mercury concentration was 27.7 microg/L (normal <2 microg/L) and the initial 24-hour urine mercury concentration was 34.4 microg/L (normal =10 microg/L). After 9 months of treatment with D-penicillamine, the patient's clinical condition, biochemical laboratory parameters, and mercury concentrations all returned to normal. The T2-weighted MRI images of the patient's brain initially showed multiple hyperintense lesions in cerebral white matter, left globus pallidus, and putamen, which also improved.
Asunto(s)
Encéfalo/efectos de los fármacos , Encéfalo/patología , Imagen por Resonancia Magnética , Intoxicación por Mercurio/patología , Acrodinia/tratamiento farmacológico , Acrodinia/etiología , Acrodinia/patología , Antídotos/uso terapéutico , Quelantes/uso terapéutico , Niño , Humanos , Exposición por Inhalación , Masculino , Intoxicación por Mercurio/complicaciones , Intoxicación por Mercurio/tratamiento farmacológico , Penicilamina/uso terapéutico , Convulsiones/inducido químicamente , Convulsiones/tratamiento farmacológico , Convulsiones/fisiopatología , Resultado del Tratamiento , Trastornos de la Visión/inducido químicamente , Trastornos de la Visión/tratamiento farmacológico , Trastornos de la Visión/patologíaRESUMEN
A3-year-old boy presented to the Hospital for Sick Children with systemic symptoms and oropharyngeal and peripheral extremity changes suggestive of Kawasaki disease. He was found to have severe hypertension. Investigation for a catecholamine-secreting tumor was negative. Toxins were considered when the patient's 20-month-old brother presented with similar symptoms, and the boys were subsequently diagnosed with elemental mercury poisoning. We review the literature on mercury intoxication and discuss the historical context, clinical syndrome (acrodynia), treatment, and radiologic findings of this unusual diagnosis.
Asunto(s)
Acrodinia/etiología , Intoxicación por Mercurio/diagnóstico , Preescolar , Diagnóstico Diferencial , Humanos , MasculinoRESUMEN
OBJECTIVES: This paper was given as a keynote address at the conference on The Assessment of the Effects Due to Low Doses of Inorganic Mercury following Environmental and Occupational Exposures: Human and in vitro Studies on the Specific Mechanisms of Toxicity in Gargnano, Italy, in September 2001. METHODS: The most relevant literature over the past 40 years has been reviewed, and in particular, the proceedings of the World Health Organisation conferences on the health effects of inorganic and organic mercury exposure have been considered. RESULTS: In an uncontaminated environment the general population is exposed to mercury vapour from the atmosphere and from dental amalgam, while the diet, mainly from fish, is the principal source for methyl mercury absorption. Mercury vapour release from amalgam fillings increases with chewing, with absorption and uptake by the brain and kidneys. Infants exposed to phenyl mercury from treated diapers and young children ingesting mercurous chloride in teething powders have developed acrodynia (pink disease), and Kawasaki disease and the use of mercurial skin lightening creams has been followed by the development of the nephrotic syndrome. Both mercury compounds and mercury vapour have given rise to contact dermatitis in the general population. Epidemics of mercury poisoning have followed release of mercury into the environment from industrial activity, with uptake of methyl mercury from fish eating in Minamata Bay and uptake of both inorganic and methyl mercury following release of mercury vapour and deposition into waterways from gold recovery procedures in the Amazon basin. The ingestion of wheat and barley seed treated with an alkyl mercury fungicide for sowing, by a largely illiterate population in Iraq, led to a major outbreak of poisoning with a high fatality rate. Following exposure to mercury vapour, the earliest clinically observed adverse effects at urine mercury levels of the order of 30-100 mg/g creatinine, are objectively detectable tremor, psychological disorder and impaired nerve conduction velocity in sensitive subjects, with subjective symptoms of irritability, fatigue and anorexia. At these and at lower levels, proteinuria has also been observed. Both glomerular and tubular damage may occur at exposure levels lower than those giving rise to central nervous system effects. An immunological effect has also been observed in studies on clinically asymptomatic workers with low level exposure. CONCLUSIONS: As mercury can give rise to allergic and immunotoxic reactions which may be genetically regulated, in the absence of adequate dose-response studies for immunologically sensitive individuals, it has not been possible to set a level for mercury in blood or urine below which mercury related symptoms will not occur.
Asunto(s)
Mercurio/efectos adversos , Acrodinia/epidemiología , Acrodinia/etiología , Adulto , Contaminantes Atmosféricos/efectos adversos , Industria Química , Niño , Preescolar , Amalgama Dental/efectos adversos , Amalgama Dental/farmacocinética , Pañales Infantiles , Brotes de Enfermedades , Hipersensibilidad a las Drogas/epidemiología , Hipersensibilidad a las Drogas/etiología , Exposición a Riesgos Ambientales , Femenino , Contaminación de Alimentos , Humanos , Lactante , Masculino , Concentración Máxima Admisible , Mercurio/farmacocinética , Compuestos de Mercurio/efectos adversos , Intoxicación por Mercurio/epidemiología , Intoxicación por Mercurio/etiología , Intoxicación del Sistema Nervioso por Mercurio/epidemiología , Intoxicación del Sistema Nervioso por Mercurio/etiología , Compuestos de Metilmercurio/efectos adversos , Compuestos de Metilmercurio/farmacocinética , Minería , Neoplasias/inducido químicamente , Síndrome Nefrótico/inducido químicamente , Síndrome Nefrótico/epidemiología , Enfermedades Profesionales/epidemiología , Enfermedades Profesionales/etiología , Exposición Profesional , Contaminantes Químicos del AguaAsunto(s)
Acrodinia/etiología , Niño , Preescolar , Familia , Humanos , Masculino , EsfigmomanometrosRESUMEN
Human contact with mercury has been ongoing for centuries and was previously considered a legitimate means of treating different cutaneous and systemic conditions. Toxicity from this heavy metal may occur from exposure to elemental, inorganic, and organic forms of mercury. This article outlines the signs and symptoms of mercury poisoning and the different clinical conditions with assorted cutaneous findings.
Asunto(s)
Mercurio/efectos adversos , Enfermedades de la Piel/inducido químicamente , Acrodinia/etiología , Adulto , Dermatitis por Contacto/etiología , Granuloma/etiología , Humanos , Hiperpigmentación/inducido químicamente , Masculino , Síndrome Mucocutáneo Linfonodular/inducido químicamente , TatuajeRESUMEN
A talidomida, droga que tem ampla aplicaçäo clínica e potentes efeitos antiinflamatórios, qualifica-se como primeira escolha para tratamento de várias doenças. Seu efeito teratogênico, entretanto, limita seu uso clínico. Baseando-se neses conhecimentos, após estudo detalhado de cada um de seus efeitos, e avaliando-se cuidadosamente o risco/benefício de seu emprego, pretende-se indicar a talidomida para algumas situaçöes clínicas já bem estabelecidas. Säo elas: eritema nodoso hansênico, lúpus eritematoso discóide, estomatite aftosa recorrente, doença enxerto-verus-hospedeiro em sua fase crônica, úlceras dolorosas de mucosas em pacientes com HIV/Aids, prurigo nodular, síndrome de Behçet e prurigo actínico. A essas somam-se outras, em que seu uso só deve se indicado se outras drogas resultarem ineficazes. Complementando a avaliaçäo, foram consideradas as situaçöes nas quais a talidomida poderia ser eficaz, necessitando de estudo prévio das características da doença e do paciente para que se efetive sua utilizaçäo. O uso da talidomida deve sempre obedecer às portarias do Ministério da Saúde que regulamentam sua fabricaçäo, indicaçöes e dispensäo. Os principais pontos dessa legislaçäo seräo destacados, em especial a proibiçäo para uso em mulheres em idade fértil.
Asunto(s)
Acrodinia/etiología , Evaluación de Medicamentos/normas , Eritema Nudoso/tratamiento farmacológico , Legislación de Medicamentos , Teratógenos , Talidomida/efectos adversos , Talidomida , Talidomida/farmacología , Talidomida/uso terapéutico , Anomalías Inducidas por MedicamentosRESUMEN
In 1890, Morvan described a syndrome of myokimia associated with muscle pain, excessive sweating and sleep disorders. The course was severe and the patient died five weeks after the onset. Several cases were published after this first report in the French literature. The last for 10 years the disease seems to have disappeared. In fact, it seems that the progress in electromyography introduced clear definitions of spontaneous muscle discharges (myokimia, neuromyotonic discharges, fibrillations, fasciculations) allowing recognition of a disease characterized by a syndrome of spontaneous and continuous muscle fiber activity associated with cramping, slow relaxation (pseudomyotonia), excessive sweating and stiffness. Different terms have been used to describe this entity: neuromyotonia (Mertens and Zschocke, 1965) or continuous muscle fibre activity (Isaacs, 1961). Classification of these syndromes has to distinguish inherited from acquired forms, idiopathic cases from cases where neuromyotonia is associated with a peripheral neuropathy, a cancer or an immunological disease. Moreover, the frequent occurrence of this later association and recent reports of improvement after plasma exchanges suggest a possible autoimmune aetiology for this group. Finally, we suggest that the term of "Maladie de Morvan" must be used instead of chorée fibrillaire but only concerning patients who exhibit central disorders including insomnia, hallucinations and altered behaviour.